- Home
- GPMT vs BSX Comparison
GPMT vs BSX Comparison
Compare GPMT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPMT
- BSX
- Stock Information
- Founded
- GPMT 2015
- BSX 1979
- Country
- GPMT United States
- BSX United States
- Employees
- GPMT N/A
- BSX 53000
- Industry
- GPMT Real Estate Investment Trusts
- BSX Medical/Dental Instruments
- Sector
- GPMT Real Estate
- BSX Health Care
- Exchange
- GPMT Nasdaq
- BSX Nasdaq
- Market Cap
- GPMT N/A
- BSX 138.5B
- IPO Year
- GPMT 2017
- BSX 1992
- Fundamental
- Price
- GPMT $1.73
- BSX $95.12
- Analyst Decision
- GPMT Buy
- BSX Strong Buy
- Analyst Count
- GPMT 3
- BSX 23
- Target Price
- GPMT $2.50
- BSX $107.61
- AVG Volume (30 Days)
- GPMT 469.8K
- BSX 10.1M
- Earning Date
- GPMT 05-06-2025
- BSX 04-23-2025
- Dividend Yield
- GPMT 11.36%
- BSX N/A
- EPS Growth
- GPMT N/A
- BSX 16.82
- EPS
- GPMT N/A
- BSX 1.25
- Revenue
- GPMT N/A
- BSX $16,747,000,000.00
- Revenue This Year
- GPMT N/A
- BSX $15.60
- Revenue Next Year
- GPMT $34.66
- BSX $10.28
- P/E Ratio
- GPMT N/A
- BSX $76.10
- Revenue Growth
- GPMT N/A
- BSX 17.61
- 52 Week Low
- GPMT $1.76
- BSX $66.80
- 52 Week High
- GPMT $4.54
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- GPMT 23.90
- BSX 45.80
- Support Level
- GPMT $1.76
- BSX $86.77
- Resistance Level
- GPMT $1.88
- BSX $96.69
- Average True Range (ATR)
- GPMT 0.16
- BSX 4.05
- MACD
- GPMT -0.05
- BSX -0.02
- Stochastic Oscillator
- GPMT 3.16
- BSX 59.74
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.